Regional anaesthesia in patients receiving antithrombotic therapy: low evidence and conservative views

Affiliations

Comment

Tindaro Mogavero. Eur J Anaesthesiol. 2023.

. 2023 Jan 1;40(1):67-68.

doi: 10.1097/EJA.0000000000001729.

¹ From the Department of Anaesthesia and Intensive Care, Santa Chiara Hospital, APSS Trento, Largo Medaglie d'Oro 9, Trento, Italy (TM).

No abstract available

Comment on

Regional anaesthesia in patients on antithrombotic drugs: Joint ESAIC/ESRA guidelines.
Kietaibl S, Ferrandis R, Godier A, Llau J, Lobo C, Macfarlane AJ, Schlimp CJ, Vandermeulen E, Volk T, von Heymann C, Wolmarans M, Afshari A. Kietaibl S, et al. Eur J Anaesthesiol. 2022 Feb 1;39(2):100-132. doi: 10.1097/EJA.0000000000001600. Eur J Anaesthesiol. 2022. PMID: 34980845

1. Kietaibl S, Ferrandis R, Godier A, et al. Regional anaesthesia in patients on antithrombotic drugs: Joint ESAIC/ESRA guidelines. Eur J Anaesthesiol 2022; 39:100–132.
1. Bouma BN, Mosnier LO. Thrombin activatable fibrinolysis inhibitor (TAFI)—how does thrombin regulate fibrinolysis? Ann Med 2006; 38:378–388.
1. Douketis JD, Syed S, Li N, et al. A physician survey of perioperative neuraxial anesthesia management in patients on a direct oral anticoagulant. Res Pract Thromb Haemost 2021; 5:159–167.
1. Testa S, Tripodi A, Legnani C, et al. START-Laboratory Register. Plasma levels of direct oral anticoagulants in real life patients with atrial fibrillation: results observed in four anticoagulation clinics. Thromb Res 2016; 137:178–183.
1. Horlocker TT. Regional anaesthesia in the patient receiving antithrombotic and antiplatelet therapy. Br J Anaesth 2011; 107: (Suppl 1): i96–i106.